🔬 LB-7SE Medical Cyclotron

2026-02-05

Compact Platform for Reliable ¹⁸F Clinical Production

The LB-7SE is LBT’s compact medical cyclotron platform, designed to support routine clinical radionuclide production in space-efficient nuclear medicine facilities.

As part of LBT’s scalable medical cyclotron portfolio, the LB-7SE emphasizes ease of installation, operational stability, and long-term reliability, making it well suited for hospitals and PET radiopharmaceutical centers where space, workflow simplicity, and dependable performance are essential.

A primary application of the LB-7SE is ¹⁸F production, supported by a niobium (Nb) liquid target configuration. This setup is widely adopted in clinical environments and is well recognized for its suitability for daily operation, helping institutions establish a stable and consistent ¹⁸F supply for routine diagnostic workflows.

Key characteristics of the LB-7SE include:

Compact system footprint, optimized for facilities with limited installation space and simplified installation requirements
System and target design optimized for routine ¹⁸F production, ensuring stable daily clinical operation, consistent output performance, and workflows aligned with common diagnostic use cases
Platform-based design, supporting long-term clinical use, simplified maintenance, and future system upgrades as operational needs evolve

Rather than serving as a standalone device, the LB-7SE is designed as part of LBT’s broader medical cyclotron ecosystem, providing a reliable foundation for cyclotron-based radionuclide production used in PET clinical applications, while allowing institutions to grow steadily as clinical demand evolves.

🌍 The LB-7SE offers a practical and dependable foundation for nuclear medicine centers building or expanding their ¹⁸F production capabilities.